Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

In the next couple of days, APC’s 2023 Compounder Profile Survey will land in the email boxes of more than 8,000 compounding professionals, including yours.

It’s an important survey. Please take time to complete it.

With our research partners at the University of Utah School of Pharmacy, APC will use the results of this every-other-year survey to produce our “Snapshot of Pharmacy Compounding in America 2023,” along with a detailed report, the “2023 National Pharmacy Compounding Demographics Study.”

Details about the wide use of pharmacy compounding have been hard to come by in recent years. This survey and the resulting reports will provide some definition for the profession here and now — how it’s structured, what compounders are doing in their businesses, and yes, what are the challenges you’re facing.

The 2023 Snapshot of Pharmacy Compounding will also be shared in meetings with members of Congress and other policy makers to help them better understand your profession.

So, watch for the link to the survey coming soon, and don’t ignore or lose it. Note: It will be sent from University of Utah College of Pharmacy, and the actual email address is surveys@qualtrics-research.com. Be sure to check your spam folder if you don’t receive it soon.

Please complete the survey so that we have the best, most robust data set possible.